These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26825096)

  • 1. Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer's Disease and Mild Cognitive Impairment.
    González-Domínguez R; Rupérez FJ; García-Barrera T; Barbas C; Gómez-Ariza JL
    Curr Alzheimer Res; 2016; 13(6):641-53. PubMed ID: 26825096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis-mass spectrometry.
    González-Domínguez R; García A; García-Barrera T; Barbas C; Gómez-Ariza JL
    Electrophoresis; 2014 Dec; 35(23):3321-30. PubMed ID: 25136972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study.
    Costa AC; Joaquim HPG; Forlenza OV; Gattaz WF; Talib LL
    Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):483-488. PubMed ID: 31218445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker.
    Peña-Bautista C; Roca M; Hervás D; Cuevas A; López-Cuevas R; Vento M; Baquero M; García-Blanco A; Cháfer-Pericás C
    J Proteomics; 2019 May; 200():144-152. PubMed ID: 30978462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution metabolomic profiling of Alzheimer's disease in plasma.
    Niedzwiecki MM; Walker DI; Howell JC; Watts KD; Jones DP; Miller GW; Hu WT
    Ann Clin Transl Neurol; 2020 Jan; 7(1):36-45. PubMed ID: 31828981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?
    Oberacher H; Arnhard K; Linhart C; Diwo A; Marksteiner J; Humpel C
    J Alzheimers Dis; 2017; 57(2):493-504. PubMed ID: 28269764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    Anal Bioanal Chem; 2014 Nov; 406(28):7137-48. PubMed ID: 25230597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    J Proteomics; 2014 Jun; 104():37-47. PubMed ID: 24473279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipidomic alterations in lipoproteins of patients with mild cognitive impairment and Alzheimer's disease by asymmetrical flow field-flow fractionation and nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry.
    Kim SH; Yang JS; Lee JC; Lee JY; Lee JY; Kim E; Moon MH
    J Chromatogr A; 2018 Sep; 1568():91-100. PubMed ID: 30007793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum metabolomic profiling in patients with Alzheimer disease and amnestic mild cognitive impairment by GC/MS.
    Sun C; Gao M; Wang F; Yun Y; Sun Q; Guo R; Yan C; Sun X; Li Y
    Biomed Chromatogr; 2020 Sep; 34(9):e4875. PubMed ID: 32384189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic investigation of systemic manifestations associated with Alzheimer's disease in the APP/PS1 transgenic mouse model.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Mol Biosyst; 2015 Sep; 11(9):2429-40. PubMed ID: 26131452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer's disease.
    Graham SF; Chevallier OP; Elliott CT; Hölscher C; Johnston J; McGuinness B; Kehoe PG; Passmore AP; Green BD
    PLoS One; 2015; 10(3):e0119452. PubMed ID: 25803028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer's Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls.
    Jasbi P; Shi X; Chu P; Elliott N; Hudson H; Jones D; Serrano G; Chow B; Beach TG; Liu L; Jentarra G; Gu H
    J Proteome Res; 2021 Sep; 20(9):4303-4317. PubMed ID: 34355917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment.
    Wang G; Zhou Y; Huang FJ; Tang HD; Xu XH; Liu JJ; Wang Y; Deng YL; Ren RJ; Xu W; Ma JF; Zhang YN; Zhao AH; Chen SD; Jia W
    J Proteome Res; 2014 May; 13(5):2649-58. PubMed ID: 24694177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of metabolomics based on direct mass spectrometry analysis for the elucidation of altered metabolic pathways in serum from the APP/PS1 transgenic model of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    J Pharm Biomed Anal; 2015 Mar; 107():378-85. PubMed ID: 25656489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomic Alterations in the Blood and Brain in Association with Alzheimer's Disease: Evidence from in vivo to Clinical Studies.
    Sriwichaiin S; Chattipakorn N; Chattipakorn SC
    J Alzheimers Dis; 2021; 84(1):23-50. PubMed ID: 34511504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOMAscan-based proteomic measurements of plasma brain natriuretic peptide are decreased in mild cognitive impairment and in Alzheimer's dementia patients.
    Begic E; Hadzidedic S; Kulaglic A; Ramic-Brkic B; Begic Z; Causevic M
    PLoS One; 2019; 14(2):e0212261. PubMed ID: 30763368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    J Pharm Biomed Anal; 2014 Sep; 98():321-6. PubMed ID: 24992214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
    Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
    J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.